key: cord-0072161-0y8ocgku
authors: Guo, Yi; Cai, Meng-Ting; Lai, Qi-Lun; Zheng, Yang; Shen, Chun-Hong; Zhang, Yin-Xi
title: Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study
date: 2021-11-29
journal: Brain Sci
DOI: 10.3390/brainsci11121577
sha: 6573a77364cdf52c5d264a24311f27e5612525ab
doc_id: 72161
cord_uid: 0y8ocgku

Paraneoplastic neurologic syndromes (PNSs) are a heterogeneous group of disorders caused by the remote effects of cancer with immune-mediated pathogenesis. Anti-Ma2 antibody was defined as one of the well-characterized onconeural antibodies that could help establish a definite PNS diagnosis. We aimed to report and explore patients with anti-Ma2 antibody-associated paraneoplastic neurologic syndrome (Ma2-PNS) who frequently exhibit sensorimotor neuropathy (SMN) using a new method of factor analysis of mixed data (FAMD). Clinical data from a case series of eight patients with definite diagnoses were retrospectively reviewed. FAMD conducted further analyses with a comprehensive visualization in R software. Our cohort, with a predominance of females (5/8), presented more frequently with SMN (4/8), followed by limbic encephalitis (LE) (3/8). Two patients with LE were found to have a testicular germ-cell tumor and a thymoma, respectively. In addition, a patient who developed chronic SMN was diagnosed with multiple myeloma (MM) involving multiple organs. FAMD exhibited the overall features into a two-dimensional coordinate and located each individual into their corresponding position with high relevance. It provided a clue for determining their potential relationships and predictors. Our findings indicated that Ma2-PNS could frequently involve the peripheral nervous system, MM might be one of its associated cancers with a presentation of chronic SMN, and FAMD might be a clinically valuable tool.

Paraneoplastic neurologic syndromes (PNSs) are a heterogeneous group of disorders caused by the remote effects of cancer with immune-mediated pathogenesis [1, 2] . They could affect any part of the nervous system from the cerebral cortex to neuromuscular junctions and muscle. Currently, the most widely used definite diagnostic criteria were firstly proposed by Graus et al. in 2004 as follows [3] : (1) a classical syndrome and cancer developing within 5 years of a neurological disorder's diagnosis; (2) non-classical syndrome resolving or significantly improving after cancer treatment without concomitant immunotherapy, provided that the syndrome is not susceptible to spontaneous remission;

(3) a non-classical syndrome with onconeural antibodies and cancer developing within 5 years of a neurological disorder's diagnosis; and (4) a neurological syndrome (classical or not) with well-characterized onconeural antibodies and no cancer. Meanwhile, classical syndromes indicated the neurological syndromes associated frequently with cancer, including

We retrospectively enrolled a cohort of 8 patients with definite Ma2-PNS [3] at the Second Affiliated Hospital School of Medicine Zhejiang University from January 2016 to December 2019. This study was approved by the ethics committee of Second Affiliated Hospital School of Medicine Zhejiang University (approval number: 2019-082). During the first hospitalization, data on demographic, clinical, paraclinical, and therapeutic characteristics were collected. The modified Rankin Scale (mRS) was employed to evaluate disease severity [21] . Prospectively collected follow-up data, including prognoses and further confirmation of associated cancers, were obtained from outpatient records or telephone calls every half year until death or May 2021.

Meanwhile, we recorded various laboratory data via serum/blood and cerebrospinal fluid (CSF) tests. In detail, white blood cells, protein, and IgG index (as determined by isoelectric focusing) in CSF corresponded to the immune-inflammatory response of the central nervous system, whereas tumor markers, coexisting antibodies, erythrocyte sedimentation rate (ESR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte to monocyte ratio (LMR) reflected peripheral or general conditions. Electroencephalogram (EEG), electromyography (EMG), magnetic resonance imaging (MRI), 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET), and computed tomography were performed to assess the individual pathological state and investigate the underlying cancers. The anti-Ma2 antibodies in serum and/or CSF were evaluated by commercial line blots (Euroimmun, Lübeck, Germany) and confirmed using indirect immunofluorescence tests on monkey cerebellum slides. Pathological examinations confirmed the presence of all cancers. 

The descriptive analyses were conducted to describe these data by median (interquartile range [IQR] ) for continuous data and number (percentage [%]) for categorical data. FAMD was used to summarize and visualize complex data and investigate their relationships. It combined principal component analysis functions for quantitative variables and multiple correspondence analysis for qualitative variables [7] . All data were normalized during the analysis to balance the influence of each set of variables. The variables comprised 12 quantitative and qualitative variables (Supplementary Materials Table S1 ). The analyses were conducted using R packages FactoMineR [22] . In our study, missing data were imputed using the Expectation-Maximization algorithm implemented in MissMDA package [23] . Corrplot package was used to display a correlation matrix [24] . A p-value of <0.05 was considered statistically significant.

Among 8 patients with a definite diagnosis, 5 were females (62.5%). The median age of onset was 56 years (IQR = 43.8-65.0 years). Except for 3 patients with a shorter disease course ranging from 19 days to 2 months, 5 patients had a chronic course lasting more than half a year. In 3 patients, limbic encephalitis was the only classical paraneoplastic neurological syndrome, whereas 4 patients experienced non-classical syndromes of sensorimotor neuropathies (SMN) and 1 patient exhibited motor neuron disease (MND). As a result, the proportion of central to peripheral syndromes was 3 to 5. Each of the 3 patients had multiple myeloma (MM) (IIIb), mixed germ cell tumor (testicular germ cell tumor and yolk sac tumor), and thymoma (IIIb). Three patients lost their lives during the follow-up while the rest remained unchanged or recovered to some degree. Among them, a 64-year-old female patient admitted to the hospital 2 years earlier for myasthenia gravis, and thymoma with lymphatic metastasis underwent thymoma resection and chemotherapy at that time. With presentation of LE at this attack, she progressed rapidly with coma and respiratory failure and was transferred to the intensive care unit following intubation. Unfortunately, she developed septic shock secondary to severe pulmonary infection, complicated with kidney failure, liver failure, and electrolyte disturbance. Finally, she lost her life as a result of cardiopulmonary arrest. Another 59-year-old female patient with chronic SMN achieved slight remission after treatment with intravenous methylprednisolone and intravenous immunoglobulin (IVIG). However, after a 19-month follow-up, she developed respiratory muscle paralysis and lost her life 1 month later. The last 47-year-old male patient with MND gradually developed dysphagia and neuromuscular respiratory failure even if treated with IVIG and eventually lost his life 7 months after the onset. Both of the latter two patients were cancer-free at the time of follow-up. Table 1 summarizes the details.

According to paraclinical data (Table 2) , two patients had Hashimoto's thyroiditis and tested positive for autoimmune antibodies. The indicators associated with inflammation were increased in varying degrees. Only two patients (No. 2 and No. 7) had an increased ESR when the cutoff value was adjusted for age and sex (male: age in years/2; female: [age in years + 10]/2) [25] . As markers of systemic inflammatory response, NLR, LMR, and PLR values varied significantly, with ranges of 1.1-3.3, 84.5-255.8, and 2.1-6.8, respectively. Among CSF results of seven patients with lumbar puncture, one patient (No.6) with LE had significantly increased CSF cells, protein, and IgG index (>0.70) [26] . These findings indicated that the blood-brain barrier was damaged due to active inflammation, corresponding to his destructive lesions of bilateral mesial temporal lobe lesions in the MRI and slow-wave activity in the EEG (Figure 1 ). 

We performed FAMD as a comprehensive and global approach to identify similarities and differences between the characteristics of each individual and explore the potential prognostic clues. It could be explained as follows:

First, data variability was explained using five principal dimensions (Dims) in FAMD. The eigenvalues quantified the variation retained by each Dim and determined the number of Dims to consider. As illustrated in Supplementary Materials Table S1 , the first Dim had larger eigenvalues than subsequent Dims, corresponding to the directions with the maximum variation in the data set. To establish a coordinate, we selected the first 2 Dims with a total of 45.1% variations, as Dim 1 and 2 each accounted for 24.6% and 20.5%, respectively.

We then analyzed a correlation between variables and the main two Dims using three parameters: coordinates, squared cosine (cos2), and contribution (Supplementary Materials Table S2 ). Correlation plots were employed to visualize the major variables associated with each Dim (Supplementary Materials Figure S1 ). Among them, the parameter of the coordinate of variables was used to create a scatter plot. The cos2 indicated the quality of representation for variables on the factor map, as indicated by the angle between the variable point and the axis. In addition, the contribution was determined using the distance of the perpendicularly project point of the variable on the corresponding Dim axis. Each variable is positioned in different quadrants of the two Dims, corresponding to their positive or negative contributions. Several variables were highlighted in a redder color, such as "LMR" and "mRS At Admission", in the quantitative plot (Figure 2A) , as well as "Oncotherapy", "Abnormal MRI", and "Abnormal EEG" in the qualitative plot ( Figure 2B ). Figure 3 supplements the bar plots for contributions. As a result, the mainly correlated variables to Dim 1 were "MRI", "Syndrome", "Classic types", and "EEG" variables, whereas "mRS At Admission", "Oncotherapy", and "LMR" were more representative for Dim 2. We further explored the relationships between each variable in two steps. Above all, we separately analyzed the quantitative and qualitative variables for detailed observations. In addition, the overall analysis of the two data sets was performed subsequently for comprehensive visualization. 

We performed FAMD as a comprehensive and global approach to identify similarities and differences between the characteristics of each individual and explore the potential prognostic clues. It could be explained as follows:

First, data variability was explained using five principal dimensions (Dims) in FAMD. The eigenvalues quantified the variation retained by each Dim and determined the number of Dims to consider. As illustrated in Supplementary Materials Table S1, the first Dim had larger eigenvalues than subsequent Dims, corresponding to the directions with the maximum variation in the data set. To establish a coordinate, we selected the first 2 Dims with a total of 45.1% variations, as Dim 1 and 2 each accounted for 24.6% and 20.5%, respectively.

We then analyzed a correlation between variables and the main two Dims using three parameters: coordinates, squared cosine (cos2), and contribution (Supplementary Materials  Table S2 ). Correlation plots were employed to visualize the major variables associated with each Dim (Supplementary Materials Figure S1 ). Among them, the parameter of the coordinate of variables was used to create a scatter plot. The cos2 indicated the quality of representation for variables on the factor map, as indicated by the angle between the variable point and the axis. In addition, the contribution was determined using the distance of the perpendicularly project point of the variable on the corresponding Dim axis. Each variable is positioned in different quadrants of the two Dims, corresponding to their positive or negative contributions. Several variables were highlighted in a redder color, such as "LMR" and "mRS At Admission", in the quantitative plot (Figure 2A) , as well as "Oncotherapy", "Abnormal MRI", and "Abnormal EEG" in the qualitative plot ( Figure 2B ). Figure 3 supplements the bar plots for contributions. As a result, the mainly correlated variables to Dim 1 were "MRI", "Syndrome", "Classic types", and "EEG" variables, whereas "mRS At Admission", "Oncotherapy", and "LMR" were more representative for Dim 2. We further explored the relationships between each variable in two steps. Above all, we separately analyzed the quantitative and qualitative variables for detailed observations. In addition, the overall analysis of the two data sets was performed subsequently for comprehensive visualization. The relationships between quantitative and qualitative variables were separately explored. As a result, the correlations between each two quantitative variables were indicated by their angle in the correlation circle (Figure 2A ). An acute and obtuse angle respectively suggested positive and negative correlations, while the orthogonal angle indicated a limited correlation. After the quantitative analysis in Figure 3 , the variables of "LMR" and "Disease course" demonstrated a good positive correlation (r = 0.80, p = 0.019), followed by the correlation between "PLR" and "NLR", "mRS at final follow-up", and "mRS at admission" (r = 0.70, p = 0.058; r = 0.70, p = 0.067). In contrast, negative correlations were obvious between "mRS at final follow-up" and "follow-up duration" (r = −1.00, p = 0.014), as well as between "age" and "CSF IgG index" (r = −0.80, p < 0.001). It could be summarized that the final outcomes of patients scored by mRS might be linked to the follow-up duration and initial severity, and patients with mild onset might have better short-term outcomes. The laboratory results revealed complicated relationships with each other, indicating their potential co-action to pathogenic mechanisms.

Referring to qualitative variables, their proximity on the plot indicated similar characteristics ( Figure 2B ). In addition, their relationships could be reflected by their distributions, corresponding to quantitative variables. Figure 4A depicts a global pattern within the data in the first quadrants. This means that variables distant from the origin continued to contribute significantly to Dims, and those in close proximity could be explained to each other. For instance, the close position in the variables of "EEG", "MRI", "syndrome", and "classic" suggested their similar profiles, e.g., patients with classic syndrome of LE usually had abnormal EEG and MRI.

farther distance between the point of the variable and the origin on the factor map. Abbreviations: ab, antibody; CSF, cerebrospinal fluid; Dim, dimension; EEG, electroencephalograms; EMG, electromyography; ESR, erythrocyte sedimentation rate; FAMD, factor analysis of mixed data; FDG-PET, 18 F-fluorodeoxyglucose positron emission tomography; IVMP, intravenous methylprednisolone; IVIG, intravenous immunoglobulin; LE, Limbic encephalitis; LMR, lymphocyte to monocyte ratio; MND, motor neuron diseases; MRI, magnetic resonance imaging; mRS, modified Rankin Scale; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; SMN, sensorimotor neuropathies. to-lymphocyte ratio.

The relationships between quantitative and qualitative variables were separately explored. As a result, the correlations between each two quantitative variables were indicated by their angle in the correlation circle (Figure 2A ). An acute and obtuse angle respectively suggested positive and negative correlations, while the orthogonal angle indicated a limited correlation. After the quantitative analysis in Figure 3 , the variables of "LMR" and "Disease course" demonstrated a good positive correlation (r = 0.80, p = 0.019), followed by the correlation between "PLR" and "NLR", "mRS at final follow-up", and "mRS at admission" (r = 0.70, p = 0.058; r = 0.70, p = 0.067). In contrast, negative correlations were obvious between "mRS at final follow-up" and "follow-up duration" (r = −1.00, p = 0.014), as well as between "age" and "CSF IgG index" (r = −0.80, p < 0.001). It could be summarized that the final outcomes of patients scored by mRS might be linked to the follow-up duration and initial severity, and patients with mild onset might have better short-term outcomes. The laboratory results revealed complicated relationships with each other, indicating their potential co-action to pathogenic mechanisms.

Referring to qualitative variables, their proximity on the plot indicated similar characteristics ( Figure 2B ). In addition, their relationships could be reflected by their distributions, corresponding to quantitative variables. Figure 4A depicts a global pattern within the data in the first quadrants. This means that variables distant from the origin continued to contribute significantly to Dims, and those in close proximity could be explained to each other. For instance, the close position in the variables of "EEG", "MRI", "syndrome", and "classic" suggested their similar profiles, e.g., patients with classic syndrome of LE usually had abnormal EEG and MRI.

Finally, we could examine the similarities and differences between individual profiles. As depicted in Figure 4B , different colored points indicate patients with corresponding mRS scores at the final follow-up. As previously stated, the positions of individuals on these two Dims can reflect their characteristics. Therefore, as an example, we could speculate that patient 2 close to Dim 2 underwent chemotherapy (combined with cancer) and eventually achieved a good outcome with an mRS of 1. Meanwhile, patient 2 might have mild severity at onset, a higher LMR value, and longer follow-up duration, based on the quantitative variables of mRS at admission, LMR, and the follow-up duration, which contributed significantly to Dim 2. Moreover, we could divide and color each individual by other variables and explore their relationships using the ellipses of the confidence intervals ( Figure 5 ). Finally, we could examine the similarities and differences between individual profiles. As depicted in Figure 4B , different colored points indicate patients with corresponding mRS scores at the final follow-up. As previously stated, the positions of individuals on these two Dims can reflect their characteristics. Therefore, as an example, we could speculate that patient 2 close to Dim 2 underwent chemotherapy (combined with cancer) and eventually achieved a good outcome with an mRS of 1. Meanwhile, patient 2 might have mild severity at onset, a higher LMR value, and longer follow-up duration, based on the quantitative variables of mRS at admission, LMR, and the follow-up duration, which contributed significantly to Dim 2. Moreover, we could divide and color each individual by other variables and explore their relationships using the ellipses of the confidence intervals ( Figure 5 ). 

We reported a series of eight patients with Ma2-PNS and analyzed their data using a novel method called FAMD. Interestingly, our cohort demonstrated a predominance of peripheral syndromes associated with SMN and identified the first Ma2-PNS associated with MM. The use of FAMD led to a comprehensive visualization of each individual and their numerous associating variables.

According to previous descriptions about demographic, clinical, and prognostic features of Ma2-PNS, typical presentations included central nervous system syndromes, such as limbic, diencephalic, or brainstem dysfunction, with abnormal MRI findings [4, 5, [27] [28] [29] . Younger males with potential testicular germ cell tumors usually responded well to treatment, and had stable neurological syndromes and long-term survival. However, isolated peripheral involvement was reported infrequently, including two cases of radiculopathy and two cases of multiple mononeuropathies [28, 30] . Our novel finding of predominant presentation of SMN could be explained by the pathological results. The paraneoplastic antigen Ma2 recognized by anti-Ma2 antibodies was expressed in central and peripheral neurons, including the brain and spinal cord, dorsal root ganglia, intestinal autonomic neurons, adrenal medullary ganglion cells, and cancers [6, [27] [28] [29] . In general, as a rare disease, its clinical features should be further evaluated using larger sample sizes. Additional in-depth mechanism studies should be conducted to explore the difference between central and peripheral involvement. In addition, our patients had high mortality even after oncotherapies and immunosuppressive treatments. Given that anti-Ma antibodies were directed against intracellular antigens, immunotherapies might be useless [28, 31] , even though an earlier treatment (within the first month after onset) was suggested as a possible way to avoid irreversible neuronal damage.

A novel cancer of MM was discovered in a 53-year-old female with mild chronic SMN. Although multiple organs were involved in MM due to plasma cell infiltration or immunoglobulin deposition, neurologic manifestations were uncommon [32] . Apart from radiculopathy, peripheral neuropathy was a rare complication in MM, usually caused by 

We reported a series of eight patients with Ma2-PNS and analyzed their data using a novel method called FAMD. Interestingly, our cohort demonstrated a predominance of peripheral syndromes associated with SMN and identified the first Ma2-PNS associated with MM. The use of FAMD led to a comprehensive visualization of each individual and their numerous associating variables.

According to previous descriptions about demographic, clinical, and prognostic features of Ma2-PNS, typical presentations included central nervous system syndromes, such as limbic, diencephalic, or brainstem dysfunction, with abnormal MRI findings [4, 5, [27] [28] [29] . Younger males with potential testicular germ cell tumors usually responded well to treatment, and had stable neurological syndromes and long-term survival. However, isolated peripheral involvement was reported infrequently, including two cases of radiculopathy and two cases of multiple mononeuropathies [28, 30] . Our novel finding of predominant presentation of SMN could be explained by the pathological results. The paraneoplastic antigen Ma2 recognized by anti-Ma2 antibodies was expressed in central and peripheral neurons, including the brain and spinal cord, dorsal root ganglia, intestinal autonomic neurons, adrenal medullary ganglion cells, and cancers [6, [27] [28] [29] . In general, as a rare disease, its clinical features should be further evaluated using larger sample sizes. Additional in-depth mechanism studies should be conducted to explore the difference between central and peripheral involvement. In addition, our patients had high mortality even after oncotherapies and immunosuppressive treatments. Given that anti-Ma antibodies were directed against intracellular antigens, immunotherapies might be useless [28, 31] , even though an earlier treatment (within the first month after onset) was suggested as a possible way to avoid irreversible neuronal damage.

A novel cancer of MM was discovered in a 53-year-old female with mild chronic SMN. Although multiple organs were involved in MM due to plasma cell infiltration or immunoglobulin deposition, neurologic manifestations were uncommon [32] . Apart from radiculopathy, peripheral neuropathy was a rare complication in MM, usually caused by associated immunoglobulin light-chain (AL) amyloidosis or polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes (POEMS) syndrome [30] . As the former consisted of 20-40% of patients in MM, about 25% of them had painful and sensory or sensorymotor symptoms, along with carpal tunnel syndrome, macroglossia, purpura, nephrotic syndrome, congestive heart failure, and orthostatic hypotension [33] [34] [35] . However, this diagnosis should be supported by positive amyloid staining with Congo red in related tissue or by the presence of amyloid fibrils on electron microscopy [36] . Meanwhile, the presentations of our patient were inconsistent with the criterion of POEMS syndrome. Moreover, MM was reported as being associated with cancer in Stiff person syndrome with positive anti-glutamic acid decarboxylase antibodies [37] . In addition, a combination of diffuse large B cell lymphoma and smoldering MM with anti-ZIC4 antibody was reported in a patient with indolent paraneoplastic cerebellar degeneration [38] . However, no combination of MM and anti-Ma2 antibodies was reported. Unfortunately, because our patient did not complete antigen expression and tissue biopsy for the diagnosis of Ma2-PNS and AL amyloidosis, respectively, her definitive diagnosis remained unknown. Above all, potential relationships between these two conditions should be considered and further validated.

We proposed a novel way of analyzing the clinical performance of eight patients using statistical techniques that enable visualization through the use of figures and tables. Although PNS is a rare disease, it exhibited complex and diverse features that could mainly be descriptive generalization rather than further systematic analyses. As the first application in observing and analyzing PNS characteristics, FAMD provided clues of similarities and differences between complicated features and indicated risk factors for outcomes via a coordinate. This means that we could speculate other potentially related characteristics and even possible prognoses in certain clinical features of a patient. However, this was only the first step in establishing their correlations; additional details should be validated with more evidence. Meanwhile, our study discovered a novel utility of NLR, LMR, and PLR in PNS. Previous research indicated their diagnostic, prognostic, and predictive roles in multiple diseases, such as cancers, coronary heart disease, pancreatitis, inflammatory autoimmune diseases, immune therapies, traumas, and mood disorders [39] [40] [41] [42] . Our study found their value to reflect the two Dims of each individual, such as disease onset age, disease course, and disease severity. These inflammatory markers might be used to monitor the severity of the inflammatory response and identify deeper pathogenic mechanisms. Above all, this visualization tool might be beneficial for future prediction of prognosis and disease management.

Several limitations should be underlined in our study. First, since this single-center retrospective study based on 2004 PNS criteria included only eight patients, with the advent of the recently proposed 2021 diagnostic criteria [43] , larger samples worldwide using new criteria should be collected for a better exhibition. In addition, a longer follow-up should be performed to track the occurrence of potential cancers and their subsequent prognosis. Second, we should acknowledge that antibody test results might reveal some false positives even if we used two methods, which could affect diagnostic accuracy. Moreover, while we focused on a few specific variables correlated with FAMD, other potential correlated factors might be considered and cannot be ruled out. Consequently, prospective studies with larger cohorts with more diverse syndromes are required to explore more details of Ma2-PNS and validate the efficacy of FAMD and its clinical utility.

Ma2-PNS could frequently involve the peripheral nervous system with a presentation of SMN. MM might be a potential associated cancer. All in all, Ma2-PNS has poor prognosis. The new application of FAMD might be beneficial in identifying distinct clinical profiles. It could prompt further reflection on the relationships between individual clinical features. To go further, in light of our results, it will be meaningful to target specific therapeutic strategies for those most at risk.

Paraneoplastic syndromes involving the nervous system

Paraneoplastic neurological syndromes

Recommended diagnostic criteria for paraneoplastic neurological syndromes

Clinical analysis of anti-Ma2-associated encephalitis

Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes

Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome

Analyse factorielle de donnees mixtes: Principe et exemple d'application

Factorial Analysis of Mixed Data

Traitement simultané de variables quantitatives et qualitatives en analyse factorielle. Les. Cah. L'anal. Données

Simultaneous analysis of qualitative and quantitative data

Analyse factorielle de données mixtes

Simple Structure in Component Analysis Techniques for Mixtures of Qualitataive and Quantitative Variables. Psychometrika 1991

Analyses factorielles simples et multiples

Exploring the Clinical Characteristics of COVID-19 Clusters Identified Using Factor Analysis of Mixed Data-Based Cluster Analysis

Assessment of Mosquito Collection Methods for Dengue Surveillance

Effects of binder choice in converter and blast furnace sludge briquette preparation: Environmental and practical implications

Underlying Factors Explaining Physical Behaviors among Office Workers-An Exploratory Analysis

Model to Analyze the Association of Rheumatoid Arthritis with Risk Factors and Their Interactions. Front. Public Health

Human Fecal Pollution Monitoring and Microbial Risk Assessment for Water Reuse Potential in a Coastal Industrial-Residential Mixed-Use Watershed

A Prospective Cohort Study to Identify Clinical, Biological, and Imaging Features That Predict the Etiology of Acute Encephalitis

Interobserver agreement for the assessment of handicap in stroke patients

FactoMineR: An R package for multivariate analysis

missMDA: A package for handling missing values in multivariate data analysis

Corrgrams: Exploratory displays for correlation matrices

Simple rule for calculating normal erythrocyte sedimentation rate

IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis

Ma2 antibody and multiple mononeuropathies

Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases

Anti Ma2-associated myeloradiculopathy: Expanding the phenotype of anti-Ma2 associated paraneoplastic syndromes

Paraneoplastic neuropathies

Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat

Review of 1027 patients with newly diagnosed multiple myeloma

The natural history of peripheral neuropathy in primary systemic amyloidosis

Amyloidosis: Review of 236 cases

Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

Stiff person syndrome

Anti-ZIC4 associated paraneoplastic cerebellar degeneration in a patient with both diffuse large B-cell lymphoma and incidental smoldering multiple myeloma

Meta-analysis of neutrophil-tolymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis

Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): Neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)

Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: A review and meta-analysis

Neutrophil-to-lymphocyte ratio: A potential new peripheral biomarker of suicidal behavior

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes